Dr. Ehab L. Atallah
Claim this profileFroedtert Hospital & the Medical College of Wisconsin
Expert in T-Lymphoblastic Leukemia/Lymphoma
Studies Myeloid Leukemia
14 reported clinical trials
38 drugs studied
Area of expertise
1T-Lymphoblastic Leukemia/Lymphoma
Global LeaderBCR-ABL1 positive
b3a2 (e14a2) positive
b2a2 (e13a2) positive
2Myeloid Leukemia
b3a2 (e14a2) positive
b2a2 (e13a2) positive
BCR-ABL1 positive
Affiliated Hospitals
Clinical Trials Ehab L. Atallah is currently running
HMPL-306
for Blood Cancers
An open label single-arm clinical trial to evaluate the safety, tolerability, PK, PD, and preliminary efficacy of HMPL-306 in subjects with advanced relapsed, refractory, or resistant hematological malignancies that harbor IDH mutations.
Recruiting1 award Phase 13 criteria
Pembrolizumab + TKI
for Chronic Myeloid Leukemia
This phase II trial studies how well pembrolizumab and dasatinib, imatinib mesylate, or nilotinib work in treating patients with chronic myeloid leukemia and persistent detection of minimal residual disease, defined as the levels of a gene product called bcr-abl in the blood. Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of cancer cells to grow and spread. Dasatinib, imatinib mesylate, and nilotinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving pembrolizumab and dasatinib, imatinib mesylate, or nilotinib may work better in treating patients with chronic myeloid leukemia.
Recruiting1 award Phase 2
More about Ehab L. Atallah
Clinical Trial Related4 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Ehab L. Atallah has experience with
- Asciminib
- Venetoclax
- Dasatinib
- Imatinib
- Nilotinib
- Azacitidine
Breakdown of trials Ehab L. Atallah has run
T-Lymphoblastic Leukemia/Lymphoma
Myeloid Leukemia
Chronic Myeloid Leukemia
Chronic Myelogenous Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ehab L. Atallah specialize in?
Ehab L. Atallah focuses on T-Lymphoblastic Leukemia/Lymphoma and Myeloid Leukemia. In particular, much of their work with T-Lymphoblastic Leukemia/Lymphoma has involved BCR-ABL1 positive patients, or patients who are b3a2 (e14a2) positive.
Is Ehab L. Atallah currently recruiting for clinical trials?
Yes, Ehab L. Atallah is currently recruiting for 7 clinical trials in Milwaukee Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Ehab L. Atallah has studied deeply?
Yes, Ehab L. Atallah has studied treatments such as Asciminib, Venetoclax, Dasatinib.
What is the best way to schedule an appointment with Ehab L. Atallah?
Apply for one of the trials that Ehab L. Atallah is conducting.
What is the office address of Ehab L. Atallah?
The office of Ehab L. Atallah is located at: Froedtert Hospital & the Medical College of Wisconsin, Milwaukee, Wisconsin 53226 United States. This is the address for their practice at the Froedtert Hospital & the Medical College of Wisconsin.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.